HighBeam QuickSearch
Get direct access to articles and research when you
add HighBeam to your browser's search toolbar.
|
-
-
Spectrum Pharmaceuticals Files Arbitration Claim Against GPC Biotech AG for Violations of Satraplatin License Agreement.
-
PR Newswire; Dec 14, 2006; 700+ Words
...PRNewswire-FirstCall/ -- Spectrum Pharmaceuticals, Inc...letter and spirit of its co-development and license agreement with GPC Biotech AG (Frankfurt Stock Exchange...Through its Demand, Spectrum seeks to enforce its rights...dealing by structuring its co-development and license...
-
-
Natural Construct Spectrum 4.5 for mainframes generating front-ends and web services.
-
M2 Presswire; Jun 9, 2003; 700+ Words
...AG: Natural Construct Spectrum 4.5 for mainframes generating...OSD. About Software AG Software AG is based in...total revenue. Software AG has offices in over 70...about 3,000. Software AG's UK offices are located...information at www.softwareag.co.uk CONTACT: Tamsin Keynton...
-
-
Releases Coverage for Spectrum Pharmaceuticals, Inc.
-
M2 Presswire; Sep 25, 2006; 700+ Words
...Releases Coverage for Spectrum Pharmaceuticals, Inc...ahead of the markets. Spectrum Pharmaceuticals, Inc...American exchanges offer. Spectrum Pharmaceuticals, Inc...The company also has co-promotion rights in...partnered with GPC Biotech AG (Frankfurt Stock Exchange...
-
-
Spectrum Pharmaceuticals Announces Positive Results of Satraplatin Pivotal Phase 3 Trial in Patients with Hormone-Refractory Prostate Cancer.
-
PR Newswire; Sep 24, 2006; 700+ Words
...PRNewswire-FirstCall/ -- Spectrum Pharmaceuticals, Inc...President and CEO of Spectrum Pharmaceuticals. "This...milestone payments due to Spectrum, on acceptance and approval...The company also has co-promotion rights in...partnered with GPC Biotech AG (Frankfurt Stock Exchange...
-
-
Spectrum Set To Sell First Branded Drug
-
Orange County Business Journal; Aug 4, 2008; ; 700+ Words
...year Generic drug maker Spectrum Pharmaceuticals Inc...month. Irvine-based Spectrum plans to introduce Fusilev...approved Fusilev in June. Spectrum has the U.S. rights...Takeda Pharmaceutical Co., Wyeth and SanofiAventis...satraplatin with GPC Biotech AG, a German conpany that...
-
-
Spectrum Pharmaceuticals Announces Start of Phase 1 Trial Evaluating Satraplatin Plus Xeloda* in Patients With Advanced Solid Tumors.
-
PR Newswire; May 16, 2006; 700+ Words
...PRNewswire-FirstCall/ -- Spectrum Pharmaceuticals, Inc...its partner, GPC Biotech AG, has initiated a Phase...agreement with GPC Biotech AG for satraplatin, GPC is...satraplatin to GPC Biotech AG in 2002, and GPC fully...GPC Biotech signed a co-development and license...
-
-
Spectrum Pharmaceuticals Announces Initiation of Phase 2 Trial Evaluating Satraplatin in Combination With Tarceva in Patients With Inoperable, Advanced Non-small Cell Lung Cancer.
-
PR Newswire; Aug 2, 2006; 700+ Words
...PRNewswire-FirstCall/ -- Spectrum Pharmaceuticals, Inc...executive officer of Spectrum. "Our partnership for...patients can take at home. Spectrum out-licensed satraplatin to GPC Biotech AG in 2002, and GPC Biotech...GPC Biotech signed a co-development and license...
-
-
Spectrum Pharmaceuticals Announces Satraplatin Shows in vitro Efficacy In Tumor Cells Resistant to Taxotere(R) and Taxol(R); Co-Development Partner GPC Biotech Presented New Data at a Conference In Florence, Italy.
-
PR Newswire; Feb 23, 2004; 700+ Words
Spectrum Pharmaceuticals, Inc...presented by GPC Biotech AG (Frankfurt Stock Exchange...Spectrum Pharmaceuticals' co-development partner...February 2004, GPC Biotech AG announced the receipt...anti-cancer drug being co-developed with GPC Biotech...
-
-
Spectrum Raises $20M, Earns Satraplatin Phase III Milestone.(Spectrum Pharmaceuticals Inc.)
-
BIOWORLD Today; Sep 30, 2003; ; 700+ Words
...a private financing, Spectrum Pharmaceuticals Inc...with partner GPC Biotech AG - initiated a Phase III...said John McManus, Spectrum's vice president of...royalty payments and could co-promote the drug in...Bristol-Meyers Squibb Co., of New York. Aside...
-
-
GPC WINS SPECTRUM DISPUTE; WIDER UNCERTAINTY CONTINUES.
-
BIOWORLD Today; Nov 7, 2007; ; 700+ Words
...Correspondent GPC Biotech AG emerged successfully from...legal dispute with partner Spectrum Pharmaceuticals Inc...against GPC regarding their co-development agreement...Possienke, analyst at Equinet AG in Frankfurt, said...Metzger, analyst at Vontobel AG, of Zurich, Switzerland...
-
-
Spectrum Pharmaceuticals Announces Presentation of New Data on Satraplatin in Prostate Cancer at AACR; Co-Development partner GPC Biotech to present new pre-clinical data at the 95th Annual Meeting of the American Association for Cancer Research (AACR) in Orlando, Florida.
-
PR Newswire; Mar 29, 2004; 700+ Words
Spectrum Pharmaceuticals, Inc...Spectrum Pharmaceuticals' co-development partner for satraplatin, GPC Biotech AG (Frankfurt Stock Exchange...February 2004, GPC Biotech AG announced the receipt...anti-cancer drug being co-developed with GPC Biotech...
-
-
Spectrum Pharmaceuticals Announces Presentation of New in vitro Data on Satraplatin at AACR Prostate Cancer Meeting.
-
PR Newswire; Nov 22, 2004; 700+ Words
...Effects of Satraplatin Spectrum Pharmaceuticals, Inc...Spectrum Pharmaceuticals' co-development partner for satraplatin, GPC Biotech AG (Nasdaq: GPCB; Frankfurt...anti-cancer drug being co-developed with GPC Biotech AG, and has been granted...
-
-
Spectrum Pharmaceuticals Announces the Expansion by its Partner of Satraplatin Phase 3 Registrational Trial in Europe after It Received 'Scientific Advice' Letter from European Drug Regulatory Authority; The Same Phase 3 Registrational Trial Will Be Used in Both Europe and the United States,...
-
PR Newswire; Feb 3, 2004; 700+ Words
Spectrum Pharmaceuticals, Inc...Spectrum Pharmaceuticals' co- development partner for satraplatin, GPC Biotech AG (Frankfurt Stock Exchange...satraplatin, thus enabling our co-development partner...spectrumpharm.com/. About co-development agreement...
-
-
Spectrum Astro and OHB-System Form Alliance for International Space and Missile Defense Programs.
-
PR Newswire; Jun 9, 2003; 700+ Words
...June 9 /PRNewswire/ -- Spectrum Astro and OHB-System...constellation. OHB-System AG is a medium-sized very...European OHB Technology AG group, which is largely...services. OHB-System AG specializes in space and...Tucson AZ, Colorado Springs CO, Herndon VA, and Washington...
-
-
Structure determination of the Ag-Cu-Sn ternary eutectic.
-
Advanced Materials & Processes; Feb 1, 2001; ; 700+ Words
...composition of 3.5 wt% Ag, 0.9 wt% Cu, 95...eutectic reaction are [Ag.sub.3]Sn, [Cu...these three phases grow co-operatively during ternary...shows the structure of the Ag-Cu-Sn ternary eutectic...copper peaks in the EDS spectrum (Fig. 4) indicates that...
-
-
Adabas, EntireX, Natural and Tamino ready for IBM mainframe; Software AG supports zSeries 990 with its enterprise mainframe products.
-
M2 Presswire; Jun 2, 2003; 700+ Words
...collaboratively to deliver a full spectrum of enterprise class solutions...Product Marketing of Software AG, Schalk Viljoen. "This...vision behind Software AG's leading enterprise...about 3,000. Software AG's UK offices are located...information at www.softwareag.co.uk CONTACT: Tamsin ...
-
-
Spectrum Announces Phase I Trial Evaluating Satraplatin in Combination with TAXOTERE(R) in Patients With Advanced Solid Tumors Opens for Accrual.
-
PR Newswire; Jul 6, 2005; 700+ Words
...PRNewswire-FirstCall/ -- Spectrum Pharmaceuticals, Inc. today announced that its co-development partner, GPC Biotech AG , has initiated a phase...cancers are planned. About Spectrum Pharmaceuticals Spectrum Pharmaceuticals is a specialty...
-
-
Spectrum Pharmaceuticals Announces Start of Phase 2 Trial With Satraplatin in Patients With Metastatic Breast Cancer.
-
PR Newswire; Nov 2, 2005; 700+ Words
...PRNewswire-FirstCall/ -- Spectrum Pharmaceuticals, Inc. today announced that its co-development partner, GPC Biotech AG (Frankfurt Stock Exchange...refractory prostate cancer. Spectrum's partner, GPC Biotech...Shaughnessy, M.D., Co-Director of US Oncology...
-
-
Satraplatin shows in vitro efficacy in taxane-resistant tumor cells.
-
Biotech Business Week; Mar 22, 2004; 700+ Words
...com & NewsRx.net) -- Spectrum Pharmaceuticals, Inc., announced...was presented by GPC Biotech AG, Spectrum Pharmaceuticals' co-development partner for satraplatin...In February 2004, GPC Biotech AG announced the receipt of a Scientific...
-
-
Independent Data Monitoring Board Holds Third Review of Safety Data.
-
PR Newswire; Dec 13, 2005; 700+ Words
...PRNewswire-FirstCall/ -- Spectrum Pharmaceuticals, Inc. today...earlier this month, GPC Biotech AG, Spectrum's co-development partner, has achieved...gpc-biotech.com/. About Spectrum Pharmaceuticals Spectrum Pharmaceuticals...
|
|